Clinical Microbiology Flashcards
Differentiate between pathogens, colonisers & contaminants.
1) Pathogens: Capable of damaging host tissues & elicit host response, producing signs & symptoms of infection
2) Colonisers: Presence of normal flora & pathogenic organisms w/o eliciting host response
3) Contaminants: Typically acquired during collections/processing of host specimens w/o eliciting host response
Name all of the normally sterile sites in our human body.
1) Genitourinary tract (except urethra & vagina)
2) Central nervous system
3) Lower respiratory tract (lungs, alveoli, bronchioles)
4) Cardiovascular system
5) Bones & joints
Why is it important to conduct microbial identification & antimicrobial susceptibility testing (AST)?
- Assist clinicians in identifying clinically significant isolates from appropriately collected specimens
- Subsequently guiding the selection of appropriate targeted antibiotic therapy in order to optimise clinical outcomes.
- Reduce infection-related & overall mortality when pt. are treated expeditiously with antibiotics to which organism is susceptible, not antibiotics which there is possible resistance against.
List the methods used for the identification of bacteria in the clinical microbiology laboratory.
1) Microscopy (w/ differential stains - Gram/acid-fast stain)
2) Culture (w/ agar / broth / differential media)
3) Biochemistry (presence of specific enzymes and/or nutrients)
4) Serologic / Immunologic diagnostics
5) Molecular / Nucleic acid-based diagnostics (PCR)
6) Mass spectroscopy (MALDI-TOF)
How long does it take to obtain the results of gram staining?
24 hours
Describe the morphology & gram stain of staphylococcus aureus.
Gram-positive cocci in clusters
Cocci are observed to be in chains under a microscope that remains purple after Gram staining. What is its likely identity?
Streptococcus spp.
Diplococcus are observed under a microscope that remains purple after Gram staining. What is its likely identity?
Streptococcus pneumoniae
Describe the morphology & gram stain of Escherichia coli.
Gram-negative rods
Briefly describe the methods used to determine the minimum inhibitory concentration (MIC) of antibiotics.
1) Agar / broth dilution method
- Quantitative
- Increasing concentrations of antimicrobial are added to each test tube containing the culture broth & microbe
- Lowest concentration of antimicrobial used that prevents visible growth of microbes = MIC
2) Kirby-Bauer disk diffusion method
- Qualitative
- Filter paper discs containing set concentrations of antimicrobials –> antimicrobials diffuse outwards
- Zone (diameter) of inhibition corresponds with antimicrobial activity
3) E-test
- Agar-based testing methods w/ graduated concentrations layered on plastic strip
- MIC = growth intersects w/ plastic strip
- Use higher value if MIC does not lie on distinct markings
Define ‘breakpoints’.
Critical concentrations predicting susceptibility & resistance to predict therapeutic response.
- MIC & diameter of zones of inhibition are often used as breakpoints.
MICs of different Abx against a particular microorganism are directly comparable. True or false?
False.
Different Abx has different MW & thus different concentrations are required to meet MIC of microbes.
Briefly explain what ‘susceptible’, ‘intermediate’ & ‘resistant’ means on an AST report.
1) Susceptible (S):
- implies infection due to isolate may be appropriately treated w/ recommended dosage of Abx
- likely therapeutic success
2) Intermediate (I):
- implies infection due to isolate may be appropriately treated with a high dose of Abx / physically concentrated in specific body sites
- uncertain response
- indicates a buffer zone that should prevent small, uncontrolled technical factors from causing major discrepancies in interpretations
3) Resistant (R):
- implies isolates are not inhibited by usually achievable concentrations of Abx w/ normal dosage schedules
- likely therapeutic failure
The Abx with the lowest MIC reported on an AST report is considered to be the best treatment option recommended. True or false?
False.
MICs are only in vitro estimate of antimicrobial activity, thus may not necessarily lead to therapeutic success in vivo.
Briefly explain the factors affecting in vivo activity of Abx.
1) Patient’s immune system
2) Protein binding of Abx affecting available free Abx circulating
3) Ability of Abx to reach site of infection
4) Drug-drug interactions
5) Ability to drain / remove infected foci
6) Expression of in vivo only enzymes that inhibit Abx activity